1217366-74-9 Usage
General Description
4-(4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile is a chemical compound with the molecular formula C15H11BrNO3. It is a white to off-white solid and is commonly used in pharmaceutical research as a building block for the synthesis of novel compounds. 4-(4-BroMo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile has potential applications in the development of drugs for various therapeutic areas such as oncology and neurology. It has also been studied for its potential antimicrobial and antifungal properties. Additionally, this chemical may have uses in the development of agrochemicals and materials science due to its unique structure and properties. However, it is important to handle this compound with care as it is a potentially hazardous material and should only be used by trained professionals in a laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 1217366-74-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,3,6 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1217366-74:
(9*1)+(8*2)+(7*1)+(6*7)+(5*3)+(4*6)+(3*6)+(2*7)+(1*4)=149
149 % 10 = 9
So 1217366-74-9 is a valid CAS Registry Number.
1217366-74-9Relevant articles and documents
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
Akama, Tsutomu,Baker, Stephen J.,Zhang, Yong-Kang,Hernandez, Vincent,Zhou, Huchen,Sanders, Virginia,Freund, Yvonne,Kimura, Richard,Maples, Kirk R.,Plattner, Jacob J.
scheme or table, p. 2129 - 2132 (2009/12/07)
A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release. 5-(4-Cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2728) showed potent activity both in vitro and in vivo. This compound is now in clinical development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis.
